Inspire Advisors’s Globus Medical GMED Stock Holding History

Inspire Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$676K	Buy	8,561 +1,151	+16%	+$97.8K	0.05%	312
2026 Q1	$638K	Buy	7,410 +1,143	+18%	+$103K	0.05%	303
2025 Q4	$547K	Buy	+6,267	New	+$476K	0.05%	301

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Inspire Advisors's GMED Position: Q2 2026 in Review

Inspire Advisors increased its Globus Medical (GMED) stake by 16% in Q2 2026, buying an estimated $97.8K and bringing the position to 8,561 shares worth $676K. The position accounts for 0.05% of the portfolio, ranked #312.

Inspire Advisors first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Inspire Advisors held 8,561 shares of Globus Medical worth $676K as of Q2 2026.
Inspire Advisors bought 1,151 Globus Medical shares in Q2 2026, an estimated $97.8K.
Globus Medical made up 0.05% of Inspire Advisors's portfolio in Q2 2026, its #312 holding.
Inspire Advisors first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.